Cite Filings / ZNTL / 0000902664-23-003640
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Zentalis Pharmaceuticals, Inc. · Filed 2023-06-20 · Acc 0000902664-23-003640

Documents 1

  • SC 13D/A Beneficial Ownership Report , p23-1815sc13da.htm

Around this filing

  • 2023-06-20 4 10% owner bought 4,760,000 shares at $22.66 ($107,861,600)
  • 2023-06-20 SC 13D/A Beneficial Ownership Report
  • 2023-06-16 8-K Bylaws or fiscal year change · Shareholder vote results
  • 2023-06-16 4 Director acquired 19,059 shares (grant or award)
  • 2023-06-16 4 Director acquired 16,364 shares (grant or award)
  • 2023-06-16 4 Director acquired 16,364 shares (grant or award)
  • 2023-06-15 8-K Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Squadron Master Fund LP 7.3%
  2. 2026-11-16 SCHEDULE 13G/A · Kush Parmar 5.3%
Loading p23-1815sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…